Aurinia Pharmaceuticals Inc. (AUPH)
USD 7.73
(0.72%)
USD 7.73
(0.72%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 97.6 Million USD | 1106.81% |
| 2022 | 8.08 Million USD | -7.45% |
| 2021 | 8.73 Million USD | 3.95% |
| 2020 | 8.4 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 1.31 Million USD | 3542.19% |
| 2012 | 36.18 Thousand USD | -54.39% |
| 2011 | 79.33 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 12.92 Million USD | 2005.78% |
| 2007 | 613.95 Thousand USD | -73.7% |
| 2006 | 2.33 Million USD | -41.11% |
| 2005 | 3.96 Million USD | -18.62% |
| 2004 | 4.87 Million USD | 1046.46% |
| 2003 | 424.9 Thousand USD | 63.55% |
| 2002 | 259.79 Thousand USD | 102.74% |
| 2001 | 128.14 Thousand USD | 20.7% |
| 2000 | 106.17 Thousand USD | -21.83% |
| 1999 | 135.81 Thousand USD | -47.85% |
| 1998 | 260.41 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 88.53 Million USD | -9.29% |
| 2024 Q2 | 85.98 Million USD | -2.88% |
| 2023 Q3 | 93.21 Million USD | -7.9% |
| 2023 FY | 97.6 Million USD | 1106.81% |
| 2023 Q4 | 97.6 Million USD | 4.71% |
| 2023 Q1 | 7.93 Million USD | -1.94% |
| 2023 Q2 | 101.2 Million USD | 1176.08% |
| 2022 Q1 | 8.57 Million USD | -1.92% |
| 2022 Q2 | 8.38 Million USD | -2.18% |
| 2022 Q3 | 8.18 Million USD | -2.34% |
| 2022 Q4 | 8.08 Million USD | -1.22% |
| 2022 FY | 8.08 Million USD | -7.45% |
| 2021 Q3 | 8.9 Million USD | -0.34% |
| 2021 FY | 8.73 Million USD | 3.95% |
| 2021 Q1 | 8.88 Million USD | 5.64% |
| 2021 Q2 | 8.93 Million USD | 0.62% |
| 2021 Q4 | 8.73 Million USD | -1.88% |
| 2020 Q3 | 8.29 Million USD | 33.8% |
| 2020 Q2 | 6.2 Million USD | 6.0% |
| 2020 Q4 | 8.4 Million USD | 1.31% |
| 2020 FY | 8.4 Million USD | 0.0% |
| 2020 Q1 | 5.85 Million USD | 0.0% |
| 2019 Q3 | 378 Thousand USD | -8.25% |
| 2019 Q1 | 421 Thousand USD | 0.0% |
| 2019 Q4 | - USD | -100.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q2 | 412 Thousand USD | -2.14% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | -100.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | -100.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q2 | 22.81 Thousand USD | -17.11% |
| 2013 Q1 | 27.51 Thousand USD | -23.95% |
| 2013 FY | 1.31 Million USD | 3542.19% |
| 2013 Q4 | 1.31 Million USD | 16895.28% |
| 2013 Q3 | 7755.09 USD | -66.0% |
| 2012 Q3 | 48.76 Thousand USD | -15.93% |
| 2012 Q2 | 58 Thousand USD | -17.32% |
| 2012 Q1 | 70.16 Thousand USD | -11.56% |
| 2012 FY | 36.18 Thousand USD | -54.39% |
| 2012 Q4 | 36.18 Thousand USD | -25.8% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | 79.33 Thousand USD | 0.0% |
| 2011 Q4 | 79.33 Thousand USD | 0.0% |
| 2010 Q3 | 440.97 Thousand USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | -100.0% |
| 2009 Q3 | - USD | -100.0% |
| 2009 Q2 | 56.84 Thousand USD | -98.41% |
| 2009 Q1 | 3.57 Million USD | -72.38% |
| 2008 Q1 | 277.85 Thousand USD | -54.74% |
| 2008 FY | 12.92 Million USD | 2005.78% |
| 2008 Q3 | 12.85 Million USD | -0.88% |
| 2008 Q4 | 12.92 Million USD | 0.57% |
| 2008 Q2 | 12.97 Million USD | 4567.9% |
| 2007 Q2 | 1.47 Million USD | -22.66% |
| 2007 FY | 613.95 Thousand USD | -73.7% |
| 2007 Q4 | 613.95 Thousand USD | -41.5% |
| 2007 Q3 | 1.04 Million USD | -28.75% |
| 2007 Q1 | 1.9 Million USD | -18.42% |
| 2006 Q1 | 3.58 Million USD | -9.68% |
| 2006 Q4 | 2.33 Million USD | -15.53% |
| 2006 Q3 | 2.76 Million USD | -13.06% |
| 2006 FY | 2.33 Million USD | -41.11% |
| 2006 Q2 | 3.17 Million USD | -11.21% |
| 2005 Q3 | 3.83 Million USD | -8.2% |
| 2005 Q1 | 4.52 Million USD | -7.09% |
| 2005 FY | 3.96 Million USD | -18.62% |
| 2005 Q4 | 3.96 Million USD | 3.48% |
| 2005 Q2 | 4.17 Million USD | -7.8% |
| 2004 Q4 | 4.87 Million USD | 16.36% |
| 2004 Q3 | 4.18 Million USD | 1191.97% |
| 2004 FY | 4.87 Million USD | 1046.46% |
| 2004 Q2 | 324.04 Thousand USD | -13.46% |
| 2004 Q1 | 374.46 Thousand USD | -11.87% |
| 2003 Q1 | 299.09 Thousand USD | 15.13% |
| 2003 FY | 424.9 Thousand USD | 63.55% |
| 2003 Q3 | 479.22 Thousand USD | -13.82% |
| 2003 Q4 | 424.9 Thousand USD | -11.34% |
| 2003 Q2 | 556.05 Thousand USD | 85.92% |
| 2002 FY | 259.79 Thousand USD | 102.74% |
| 2002 Q3 | 290.47 Thousand USD | -13.96% |
| 2002 Q1 | 360.52 Thousand USD | 0.0% |
| 2002 Q2 | 337.61 Thousand USD | -6.35% |
| 2002 Q4 | 259.79 Thousand USD | -10.56% |
| 2001 Q2 | 80.64 Thousand USD | -13.94% |
| 2001 Q3 | 66.46 Thousand USD | -17.59% |
| 2001 Q1 | 93.71 Thousand USD | -11.73% |
| 2001 FY | 128.14 Thousand USD | 20.7% |
| 2000 Q2 | 200.22 Thousand USD | 45.27% |
| 2000 Q3 | 178.56 Thousand USD | -10.82% |
| 2000 Q1 | 137.83 Thousand USD | 1.48% |
| 2000 Q4 | 106.17 Thousand USD | -40.54% |
| 2000 FY | 106.17 Thousand USD | -21.83% |
| 1999 Q3 | 200.72 Thousand USD | -80.27% |
| 1999 Q2 | 1.01 Million USD | 91.82% |
| 1999 Q1 | 530.32 Thousand USD | 0.0% |
| 1999 Q4 | 135.81 Thousand USD | -32.34% |
| 1999 FY | 135.81 Thousand USD | -47.85% |
| 1998 FY | 260.41 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Agenus Inc. | 350.24 Million USD | 72.132% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | 16.713% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -43.056% |
| Acelyrin, Inc. | 1.19 Million USD | -8074.791% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 57.412% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -114.474% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -4504.104% |
| IO Biotech, Inc. | 2.49 Million USD | -3813.673% |
| Ardelyx, Inc. | 55.98 Million USD | -74.354% |
| Geron Corporation | 85.89 Million USD | -13.63% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -1388.138% |
| Innoviva, Inc. | 449.07 Million USD | 78.265% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 3.27 Million USD | -2878.547% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -1483.244% |
| Onconetix, Inc. | 9.88 Million USD | -887.348% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -30594.025% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -11974.067% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -3298.572% |
| Vaxcyte, Inc. | 29.22 Million USD | -233.996% |
| Pharming Group N.V. | 171.54 Million USD | 43.101% |
| ContextLogic Inc. | 6 Million USD | -1526.783% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -9983.368% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -357.583% |
| AlloVir, Inc. | 27.42 Million USD | -255.853% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | 11.554% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -33599.071% |
| Summit Therapeutics Inc. | 106.09 Million USD | 8.004% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -1472.278% |
| Senti Biosciences, Inc. | 37.66 Million USD | -159.138% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -1174.676% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -174.522% |
| PDS Biotechnology Corporation | 23.85 Million USD | -309.226% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -479.958% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -203.901% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | 29.794% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -241.989% |
| Elevation Oncology, Inc. | 30.13 Million USD | -223.878% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | 6.311% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -96540.594% |
| AbCellera Biologics Inc. | 77.38 Million USD | -26.14% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -21562.957% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -156.159% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -10673.4% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -652.212% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -1289.621% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -121410.557% |
| Vaxxinity, Inc. | 15.16 Million USD | -543.506% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -5804.84% |
| Structure Therapeutics Inc. | 5.45 Million USD | -1689.968% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -20448.842% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -1328.047% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -41528.602% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -45510.748% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Opthea Limited | 200.62 Million USD | 51.349% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -890.733% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -57.24% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -401.965% |
| Molecular Templates, Inc. | 12.23 Million USD | -698.095% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | 27.432% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -281.934% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 53.552% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -5685.833% |
| ADMA Biologics, Inc. | 141.41 Million USD | 30.98% |
| Alkermes plc | 290.73 Million USD | 66.427% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 96.362% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -32358.416% |
| AnaptysBio, Inc. | 17.81 Million USD | -447.923% |
| Aptorum Group Limited | 3.36 Million USD | -2802.899% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | 15.25% |
| Bicycle Therapeutics plc | 44.95 Million USD | -117.117% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | 3.725% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -37.521% |
| Clearside Biomedical, Inc. | 43 Million USD | -126.988% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -5532.256% |
| Chimerix, Inc. | 2.14 Million USD | -4452.565% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -2644.082% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -367.372% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -255.128% |
| CRISPR Therapeutics AG | 238.63 Million USD | 59.097% |
| Precision BioSciences, Inc. | 31.26 Million USD | -212.163% |
| Dyadic International, Inc. | 136.92 Thousand USD | -71182.928% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -1689.313% |
| Fate Therapeutics, Inc. | 103.53 Million USD | 5.727% |
| Fortress Biotech, Inc. | 88.59 Million USD | -10.176% |
| Fortress Biotech, Inc. | 88.59 Million USD | -10.176% |
| GT Biopharma, Inc. | 58 Thousand USD | -168187.931% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -176836.463% |
| ImmuCell Corporation | 11.96 Million USD | -715.478% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -15592.368% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Incyte Corporation | 38.28 Million USD | -154.935% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -61676.582% |
| Jaguar Health, Inc. | 35.86 Million USD | -172.189% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -297.714% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -575.762% |
| MiMedx Group, Inc. | 48.09 Million USD | -102.929% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Mesoblast Limited | 118.92 Million USD | 17.924% |
| Novavax, Inc. | 280.63 Million USD | 65.219% |
| NextCure, Inc. | 6.6 Million USD | -1377.774% |
| Precigen, Inc. | 7.09 Million USD | -1275.328% |
| PureTech Health plc | 25.51 Million USD | -282.593% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -61.123% |
| Seer, Inc. | 28.25 Million USD | -245.401% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -5869.847% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -289.773% |
| Aptose Biosciences Inc. | 1 Million USD | -9565.916% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -1127522.458% |
| Soligenix, Inc. | 3.49 Million USD | -2693.112% |
| Century Therapeutics, Inc. | 48.17 Million USD | -102.626% |
| Kura Oncology, Inc. | 17.2 Million USD | -467.483% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -5.598% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -4439.86% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -598.49% |
| Autolus Therapeutics plc | 52.96 Million USD | -84.279% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -1684.732% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -133.27% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 57.457% |
| GRI Bio, Inc. | 14 Thousand USD | -697092.857% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -685.633% |
| IGM Biosciences, Inc. | 40.5 Million USD | -140.969% |
| INmune Bio, Inc. | 10.43 Million USD | -835.202% |
| Heron Therapeutics, Inc. | 179.62 Million USD | 45.662% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -1552.379% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -119399.265% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -11704.766% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -88.521% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -67.477% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -68.66% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 79.701% |
| Verastem, Inc. | 41.55 Million USD | -134.875% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -1707.537% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -758.31% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -894.67% |
| Histogen Inc. | 4.62 Million USD | -2011.791% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -2788.636% |
| Organovo Holdings, Inc. | 1.39 Million USD | -6901.937% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -112.181% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -1779.226% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -359.565% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -457075.644% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -15.391% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -46597.445% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -223.031% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -60033.566% |
| Apollomics, Inc. | 4.66 Million USD | -1994.121% |
| Amarin Corporation plc | 8.73 Million USD | -1017.168% |
| Turnstone Biologics Corp. | 3.21 Million USD | -2936.932% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -15.274% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -39417.004% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | 48.613% |
| Better Therapeutics, Inc. | 14.88 Million USD | -555.961% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -218.831% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | 12.009% |
| NLS Pharmaceutics AG | 1.63 Million USD | -5874.429% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -1492.284% |
| Gritstone bio, Inc. | 104.77 Million USD | 6.841% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -3403.482% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -199627.849% |
| Avid Bioservices, Inc. | 207.83 Million USD | 53.036% |
| Insmed Incorporated | 1.2 Billion USD | 91.893% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -1354.433% |
| OmniAb, Inc. | 25.56 Million USD | -281.859% |
| Alector, Inc. | 38.91 Million USD | -150.802% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 54.376% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -544.228% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 79.599% |
| Aura Biosciences, Inc. | 19.55 Million USD | -399.09% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -54.522% |
| Immunic, Inc. | 1.33 Million USD | -7216.867% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -207.598% |
| Veracyte, Inc. | 12.63 Million USD | -672.819% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 84.864% |
| FibroGen, Inc. | 170.45 Million USD | 42.737% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -974.849% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -47767.452% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 98.316% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -263702.703% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -2203.682% |
| TG Therapeutics, Inc. | 110.79 Million USD | 11.903% |
| Galecto, Inc. | 249 Thousand USD | -39099.598% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -5758.764% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 94.183% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -1233.976% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -1708.542% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -3403.482% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -263.108% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -116.553% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -6778.576% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -115.773% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -126.104% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -102.382% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 88.499% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -9400.408% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -790.981% |
| NexImmune, Inc. | 68.8 Thousand USD | -141752.083% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -687563.802% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 96.389% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -24799.618% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -1313.365% |
| Ainos, Inc. | 5.96 Million USD | -1536.725% |
| Pluri Inc. | 29.61 Million USD | -229.62% |
| Prothena Corporation plc | 11.83 Million USD | -724.732% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -286.792% |
| Celularity Inc. | 65.41 Million USD | -49.207% |
| Rallybio Corporation | 392 Thousand USD | -24799.745% |
| Cue Biopharma, Inc. | 14.69 Million USD | -564.219% |
| MeiraGTx Holdings plc | 89.26 Million USD | -9.346% |
| Omeros Corporation | 338.28 Million USD | 71.146% |
| Humacyte, Inc. | 58.1 Million USD | -67.981% |
| Immunocore Holdings plc | 84.03 Million USD | -16.155% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -5167.512% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -1901.374% |
| Blueprint Medicines Corporation | 774.12 Million USD | 87.391% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -1845.138% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -57.894% |
| Sana Biotechnology, Inc. | 104.09 Million USD | 6.234% |
| Pulmatrix, Inc. | 8.75 Million USD | -1014.744% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -1311.118% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -604.744% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | 15.379% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -209.392% |
| Cytokinetics, Incorporated | 755.77 Million USD | 87.085% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -629.281% |
| Nutriband Inc. | 241.28 Thousand USD | -40352.991% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -1685.385% |
| Vor Biopharma Inc. | 35.66 Million USD | -173.716% |
| Roivant Sciences Ltd. | 499.74 Million USD | 80.469% |
| Evogene Ltd. | 1.13 Million USD | -8477.065% |
| ProKidney Corp. | 4.41 Million USD | -2111.806% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -7861.419% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 94.39% |
| CorMedix Inc. | 667.63 Thousand USD | -14519.88% |
| BioLineRx Ltd. | 11.59 Million USD | -742.093% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -150.789% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -35.93% |
| Atai Life Sciences N.V. | 16.47 Million USD | -492.419% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -3882.34% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -14360.296% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -113.241% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -150064.615% |
| MediciNova, Inc. | 215.92 Thousand USD | -45103.912% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -3812.104% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -7640.272% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | 47.628% |
| Biomea Fusion, Inc. | 10.29 Million USD | -848.009% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 76.482% |
| Mereo BioPharma Group plc | 5.95 Million USD | -1539.903% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -2618.858% |
| Absci Corporation | 15.95 Million USD | -511.688% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -965.462% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -565.306% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -256.035% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -696.272% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -680.481% |
| Allakos Inc. | 41.46 Million USD | -135.396% |
| Imunon, Inc. | 1.62 Million USD | -5907.642% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -802.015% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -64540.397% |
| BioAtla, Inc. | 2.46 Million USD | -3867.764% |
| NLS Pharmaceutics AG | 1.63 Million USD | -5874.429% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -86277.876% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -2.614% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -1659.953% |
| XOMA Corporation | 124.45 Million USD | 21.569% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -415.539% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -126.115% |
| aTyr Pharma, Inc. | 15.09 Million USD | -546.618% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -776.342% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -274.792% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -363.735% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -27867.622% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -29795.587% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -5881.829% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 93.49% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -59428.442% |
| UroGen Pharma Ltd. | 100.21 Million USD | 2.601% |
| Sutro Biopharma, Inc. | 182.74 Million USD | 46.59% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -28082.259% |
| Orgenesis Inc. | 22.62 Million USD | -331.488% |
| Entera Bio Ltd. | 390 Thousand USD | -24927.436% |
| GH Research PLC | 343 Thousand USD | -28356.851% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -31902.295% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -9931.552% |
| Xencor, Inc. | 83.43 Million USD | -16.987% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -56427.077% |
| Replimune Group, Inc. | 75.86 Million USD | -28.652% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -7872.956% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -937.931% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -59428.442% |
| Portage Biotech Inc. | 47 Thousand USD | -207574.468% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -7640.272% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -3938.353% |
| OncoCyte Corporation | 2.86 Million USD | -3302.126% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -7412.762% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -64731.888% |
| Purple Biotech Ltd. | 351 Thousand USD | -27708.262% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -2989.807% |
| scPharmaceuticals Inc. | 40.26 Million USD | -142.387% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -90.665% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -68637.324% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -1765.934% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -265.05% |
| Curis, Inc. | 2.79 Million USD | -3393.45% |
| Daré Bioscience, Inc. | 5.31 Million USD | -1735.358% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -4468.656% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -17175.575% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -483.39% |
| BeiGene, Ltd. | 930.18 Million USD | 89.507% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -528.001% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -10.988% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -8454.514% |
| Erasca, Inc. | 55.85 Million USD | -74.738% |
| bluebird bio, Inc. | 330.32 Million USD | 70.451% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 91.392% |
| DBV Technologies S.A. | 14.38 Million USD | -578.722% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -3801.159% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -2001.787% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 75.887% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -112.009% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -2017.748% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -3739.772% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -417.727% |
| MacroGenics, Inc. | 33.97 Million USD | -187.324% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -366.483% |
| Prime Medicine, Inc. | 13.63 Million USD | -615.961% |
| Aditxt, Inc. | 18.21 Million USD | -435.773% |
| Adagene Inc. | 22.3 Million USD | -337.565% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -537.829% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 84.024% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -380.989% |
| SciSparc Ltd. | 76 Thousand USD | -128330.263% |
| Vericel Corporation | 88.14 Million USD | -10.737% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -19.009% |
| Generation Bio Co. | 97.89 Million USD | 0.293% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -29567.781% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -285.829% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | 52.599% |
| Invivyd, Inc. | 2.16 Million USD | -4408.406% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -82.559% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -2769890.89% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -1660.906% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -154831.746% |
| 2seventy bio, Inc. | 256.67 Million USD | 61.972% |
| Clene Inc. | 32.16 Million USD | -203.495% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -1639.207% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -4346.788% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -92.625% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -20182.185% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | 49.477% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -223.996% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -467.582% |
| Vir Biotechnology, Inc. | 124.54 Million USD | 21.626% |
| Evaxion Biotech A/S | 10.86 Million USD | -797.975% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -17.05% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -30.304% |
| Trevena, Inc. | 35.23 Million USD | -177.033% |
| Surrozen, Inc. | 3.37 Million USD | -2788.636% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -1402.571% |
| Cingulate Inc. | 3.13 Million USD | -3013.363% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -237965.854% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -261.641% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -19386.208% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -16086.899% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -70.627% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -20890.753% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -245.243% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -382.749% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -6176.977% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -7646.587% |
| Statera Biopharma, Inc. | 16.26 Million USD | -500.247% |
| ImmunityBio, Inc. | 883.67 Million USD | 88.954% |
| Korro Bio, Inc. | 33.2 Million USD | -193.935% |
| Kineta, Inc. | 1.31 Million USD | -7311.314% |
| BioVie Inc. | 6.11 Million USD | -1497.118% |
| Codexis, Inc. | 22.36 Million USD | -336.447% |
| Celularity Inc. | 65.41 Million USD | -49.207% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -88.693% |
| Celcuity Inc. | 37.44 Million USD | -160.659% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -43416.273% |
| Cibus, Inc. | 24.62 Million USD | -296.438% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -25384.856% |
| IN8bio, Inc. | 4.89 Million USD | -1894.829% |
| Kodiak Sciences Inc. | 181.63 Million USD | 46.261% |
| Annexon, Inc. | 31.35 Million USD | -211.296% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -30.08% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -4067.677% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -2400.82% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 93.285% |
| Eyenovia, Inc. | 16.1 Million USD | -505.963% |
| Puma Biotechnology, Inc. | 111.49 Million USD | 12.452% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -9809.34% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -751.942% |
| Arcellx, Inc. | 97.62 Million USD | 0.018% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -4441.973% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -268.148% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -3046.583% |
| Moolec Science SA | 2.64 Million USD | -3589.843% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -242.637% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -1446.127% |
| Royalty Pharma plc | 6.13 Billion USD | 98.409% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -3963.572% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -84588.601% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -188.522% |
| Humacyte, Inc. | 58.1 Million USD | -67.981% |
| 89bio, Inc. | 27.1 Million USD | -260.067% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -634.661% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -3774.831% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -7194.993% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | 7.973% |
| Notable Labs, Ltd. | 2.04 Million USD | -4663.641% |
| Liquidia Corporation | 3.5 Million USD | -2686.383% |
| Mustang Bio, Inc. | 2.49 Million USD | -3807.406% |
| Immunovant, Inc. | 138 Thousand USD | -70629.71% |
| Quantum-Si incorporated | 15.3 Million USD | -537.829% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -1019.218% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -24301.75% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -81.736% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -119399.265% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -795.231% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -46271.544% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -47982.266% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -372.421% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -24120.099% |
| PepGen Inc. | 20.1 Million USD | -385.51% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -16904.704% |
| United Therapeutics Corporation | 700 Million USD | 86.056% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -271.624% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -2087.047% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -10916.591% |
| XOMA Corporation | 124.45 Million USD | 21.569% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -35522.993% |
| Bionomics Limited | 239.61 Million USD | 59.266% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -4698.773% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -635.214% |
| uniQure N.V. | 138.4 Million USD | 29.479% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -14.263% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -9358.043% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -9809.34% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -974.849% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -5487.121% |
| Altimmune, Inc. | 671 Thousand USD | -14446.498% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 78.069% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -635.214% |
| Compugen Ltd. | 1.35 Million USD | -7124.796% |
| Peak Bio, Inc. | 10.72 Million USD | -810.36% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -128.235% |
| Benitec Biopharma Inc. | 284 Thousand USD | -34268.662% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -15.436% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -389.97% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -728.653% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -6.723% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -389.97% |
| Instil Bio, Inc. | 86.05 Million USD | -13.425% |
| argenx SE | 20 Million USD | -388.035% |
| Immunome, Inc. | 1.65 Million USD | -5815.576% |
| Verona Pharma plc | 51.32 Million USD | -90.16% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -898.231% |
| Shattuck Labs, Inc. | 4.2 Million USD | -2222.87% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -26863.26% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -2234.537% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -16584.957% |
| Moolec Science SA | 2.64 Million USD | -3589.843% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -223.103% |
| Design Therapeutics, Inc. | 3.05 Million USD | -3100.23% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -37154.58% |
| NeurAxis, Inc. | 224.26 Thousand USD | -43424.035% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -586.021% |
| Lumos Pharma, Inc. | 6.58 Million USD | -1382.263% |
| Achilles Therapeutics plc | 4.61 Million USD | -2014.995% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -898.231% |
| 180 Life Sciences Corp. | 1.32 Million USD | -7294.083% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -471.465% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -6176.977% |
| Nutriband Inc. | 241.28 Thousand USD | -40352.991% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -855.713% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -11716.828% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 73.882% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -224.287% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -2539.549% |
| Palisade Bio, Inc. | 369 Thousand USD | -26351.762% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -23419.759% |
| Beam Therapeutics Inc. | 173.17 Million USD | 43.636% |
| Neurogene Inc. | 16.25 Million USD | -500.474% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 68.324% |
| AEON Biopharma, Inc. | 278 Thousand USD | -35010.432% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -29036.418% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -91214.517% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -28.664% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -59.731% |
| Athira Pharma, Inc. | 1.58 Million USD | -6058.17% |
| Vaccinex, Inc. | 247 Thousand USD | -39417.004% |
| HCW Biologics Inc. | 6.45 Million USD | -1412.87% |
| XOMA Corporation | 124.45 Million USD | 21.569% |
| Nektar Therapeutics | 230.4 Million USD | 57.636% |
| Arvinas, Inc. | 3.4 Million USD | -2770.794% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -5881.829% |
| Merus N.V. | 12.16 Million USD | -702.557% |
| Omega Therapeutics, Inc. | 128.42 Million USD | 23.999% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -606.58% |
| Rezolute, Inc. | 2.22 Million USD | -4280.925% |
| Clene Inc. | 32.16 Million USD | -203.495% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -55658.542% |
| BeyondSpring Inc. | 3.99 Million USD | -2343.229% |
| Synlogic, Inc. | 17.27 Million USD | -465.019% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -7408.231% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -278777.143% |
| Peak Bio, Inc. | 10.72 Million USD | -810.36% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -87.984% |
| Krystal Biotech, Inc. | 8.09 Million USD | -1105.918% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | 44.86% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -1283.123% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -71357.751% |
| MannKind Corporation | 382.37 Million USD | 74.474% |
| Ikena Oncology, Inc. | 10.73 Million USD | -808.987% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -23764.792% |
| Gossamer Bio, Inc. | 212.46 Million USD | 54.06% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -55995.977% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -965.462% |
| Legend Biotech Corporation | 328.67 Million USD | 70.303% |
| Mural Oncology plc | 15 Million USD | -550.323% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -105.809% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -4545.74% |
| Champions Oncology, Inc. | 7.43 Million USD | -1213.688% |
| REGENXBIO Inc. | 89.29 Million USD | -9.315% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -11320.071% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -17551.027% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -1702.863% |
| Vaxart, Inc. | 26.51 Million USD | -268.134% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -523.394% |
| Cellectis S.A. | 92.85 Million USD | -5.12% |
| Longeveron Inc. | 2.04 Million USD | -4682.313% |
| Repare Therapeutics Inc. | 3.41 Million USD | -2762.375% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 93.012% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -109.493% |
| Revolution Medicines, Inc. | 87.94 Million USD | -10.988% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -56320.231% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -2369.188% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -30690.852% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -55675.429% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 87.926% |
| Denali Therapeutics Inc. | 52.24 Million USD | -86.84% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -577.569% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -7003.857% |
| Cingulate Inc. | 3.13 Million USD | -3013.363% |
| Passage Bio, Inc. | 26.29 Million USD | -271.214% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -1364.471% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -23823.284% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -10818.009% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -374.719% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -7646.587% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -3882.137% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -3025.424% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -11935.388% |
| OmniAb, Inc. | 25.56 Million USD | -281.859% |
| Anew Medical, Inc. | 1.6 Million USD | -5981.433% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -229.944% |
| Lipocine Inc. | 17.16 Thousand USD | -568506.548% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -738.692% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -181.873% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -1552.379% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -70.722% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -47982.266% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -1789.777% |
| Ocugen, Inc. | 6.94 Million USD | -1306.238% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -590.827% |
| Q32 Bio Inc. | 1.31 Million USD | -7305.69% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -14424.851% |
| Alumis Inc. Common Stock | 32.58 Million USD | -199.592% |
| Equillium, Inc. | 824 Thousand USD | -11745.51% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -975.085% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -32348.488% |
| Galera Therapeutics, Inc. | 152.29 Million USD | 35.911% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -90.87% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -12493.672% |
| Dominari Holdings Inc. | 3.02 Million USD | -3123.481% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -103202.042% |
| vTv Therapeutics Inc. | 529 Thousand USD | -18351.229% |
| Bio-Techne Corporation | 419.53 Million USD | 76.735% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -35.573% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | 49.574% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -477.967% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -328.816% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -1511.208% |
| Nkarta, Inc. | 88.33 Million USD | -10.491% |
| BioCardia, Inc. | 1.31 Million USD | -7322.586% |
| Iterum Therapeutics plc | 19.5 Million USD | -400.318% |